Interaction between vitamin D receptor with caveolin-3 and regulation by 1,25-dihydroxyvitamin D3 in adult rat cardiomyocytes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 159-163

  Zhao, Guisheng ^a   Simpson, Robert U ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardiomyocyte; Caveolin 3; Heart; VDR; Vitamin D

Indexed keywords

1ALPHA,25 DIHYDROXYLUMISTEROL; CALCITRIOL; CAVEOLIN 3; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; ERGOSTEROL; PROTEIN BINDING; VITAMIN D;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; MALE; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SARCOLEMMA; SARCOMERE LENGTH; SIGNAL TRANSDUCTION; TRANSVERSE TUBULAR SYSTEM; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; HEART MUSCLE; METABOLISM; SARCOPLASMIC RETICULUM; SPRAGUE DAWLEY RAT;

ANIMALS; CAVEOLIN 3; ERGOSTEROL; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; VITAMIN D;

RATTUS;

EID: 77954760267     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.055     Document Type: Article

References (26)

1. Nemerovski C.W., Dorsch M.P., Simpson R.U., Bone H.G., Aaronson K.D., Bleske B.E. Vitamin D and cardiovascular disease. Pharmacotherapy 2009, 29(June (6)):691-708.
2. 3 and cardiovascular function in rats. J. Clin. Invest. 1987, 79:1706-1712.
3. Shane E., Mancini D., Aaronson K., Silverberg S.J., Seibel M.J., Addesso V., et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am. J. Med. 1997, 103:197-207.
4. 3 regulation of myocardial growth and c-myc levels in the rat heart. Biochem. Biophys. Res. Commun. 1995, 213:59-65.
5. 3 with cardiovascular function. III. Effects on physical and morphological properties. Am. J. Physiol. 1990, 258:E134-E142.
6. Simpson R.U., Hershey S.H., Nibbelink K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J. Steroid Biochem. Mol. Biol. 2007, 103:521-524.
7. De Boland A.R., Boland R.L. Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal. 1994, 6:717-724.
8. Morelli S., Buitrago C., Boland R., de Boland A.R. The stimulation of MAP kinase by 1,25(OH)(2)-vitamin D(3) in skeletal muscle cells is mediated by protein kinase C and calcium. Mol. Cell Endocrinol. 2001, 173:41-52.
9. Norman A.W. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006, 147:5542-5548.
10. 3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J. Cell Biochem. 2002, 86:128-135.
11. 3 in vivo and in vitro. Mol. Endocrinol. 2004, 18:2660-2671.
12. Tishkoff D.X., Nibbelink K.A., Holmberg K.H., Dandu L., Simpson R.U. Functional vitamin D receptor in the T-tubules of cardiac myocytes. Endocrinology 2008, 149(2):558-564.
13. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 2002, 54:431-467.
14. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
15. Galbiati F., Razani B., Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell 2001, 106:403-411.
16. Green J.J., Robinson D.A., Wilson G.E., Simpson R.U., Westfall M.V. Calcitriol modulation of cardiac contractile performance via protein kinase C. J. Mol. Cell Cardiol. 2006, 41:350-359.
17. 3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J. Steroid Biochem. Mol. Biol. 2007, 103:533-537.
18. 3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J. Biol. Chem. 2005, 280:14130-14137.
19. Williams T.M., Lisanti M.P. The caveolin genes: from cell biology to medicine. Ann. Med. 2004, 36:584-595.
20. 3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology 1998, 139:457-465.
21. 2+ concentration in pancreatic beta-cells through nongenomic signal transduction. Endocrinology 1999, 140:4706-4712.
22. Schwartz Z., Ehland H., Sylvia V.L., Larsson D., Hardin R.R., Bingham V., et al. 1alpha,25-Dihydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase. Endocrinology 2002, 143:2775-2786.
23. Franzini-Armstrong C. Simultaneous maturation of transverse tubules and sarcoplasmic reticulum during muscle differentiation in the mouse. Dev. Biol. 1991, 146:353-363.
24. (2+) channels of cardiac myocytes. Am. J. Physiol. Cell Physiol. 2000, 279:C1963-C1969.
25. Ostrom R.S., Violin J.D., Coleman S., Insel P.A. Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol. Pharmacol. 2000, 57:1075-1079.
26. (2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7500-7505.